An Adaptative Randomized Phase II Study on the Timing of FOLFOX for Patients With Operable Stage III Rectal Cancer.

Trial Profile

An Adaptative Randomized Phase II Study on the Timing of FOLFOX for Patients With Operable Stage III Rectal Cancer.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 06 Feb 2018

At a glance

  • Drugs Fluorouracil (Primary) ; Folinic acid (Primary) ; Oxaliplatin (Primary)
  • Indications Rectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 May 2018.
    • 05 Jun 2017 Status changed from recruiting to active, no longer recruiting.
    • 19 Jan 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2017, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top